Satellite Banner
Technology Networks Header
Tuesday, September 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Protect Pipette After Over Pipetting with Eppendorf
Wednesday, February 05, 2014
New ep Dualfilter T.I.P.S® SealMax filter tips from Eppendorf.

Illumina Unveils Strategic Roadmap for Market Expansion
Saturday, February 01, 2014
Company positions for growth in key genomics segments, introduces new workflow solutions at investor day.

Roche Announces the Launch of SeqCap Epi Target Enrichment System
Saturday, February 01, 2014
Novel NGS target enrichment solution for methylation assessment.

At BiOS SCHOTT to Present a Variety of Glass Substrates for Use in Biotechnology
Friday, January 31, 2014
Specialty glass and in-house micro-structuring technology for top quality substrates.

Maverix, $100,000 Order from University of Missouri For 99 Lives Cat Whole Genome Sequencing Initiative
Wednesday, January 29, 2014
Maverix Analytic Platform to be Used for Analysis and Hosting of Community of Discovery.

Sapio Sciences Announces Exemplar NGS LIMS for Next Gen Sequencing Labs
Monday, January 27, 2014
Exemplar NGS provides pre-built, clinical standard workflows for leading NGS platforms

PerkinElmer Introduces Novel Research Tools at SLAS 2014
Monday, January 27, 2014
PerkinElmer Inc. introduced several novel products at SLAS2014, including the Opera® Phenix™ high content screening system, JANUS® chemagic nucleic acid workstation.

Fluxion Biosciences Releases IsoFlux Rare Cell Enrichment Kit
Tuesday, January 21, 2014
New bead chemistry enables more options for targeted cell enrichment.

Exiqon Launches Next Generation Sequencing Services
Tuesday, January 21, 2014
Services provide a complete sample-to-answer solution including biological interpretation of customer’s results.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 206
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv